Centro Hospitalar de Vila Nova de Gaia/Espinho, Epe-Unidade L

Vila Nova de Gaia 4434-502

0 studies enrolling now · 1 studies all time

What they study most

Head and Neck Cancer

Studies at this site

• Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck — Running, not enrolling